National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Search
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Merkel Cell Carcinoma Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 07/26/2007



General Information About Merkel Cell Carcinoma






Stages of Merkel Cell Carcinoma






Recurrent Merkel Cell Carcinoma






Treatment Option Overview







Treatment Options by Stage






Treatment Options for Recurrent Merkel Cell Carcinoma






Get More Information From NCI






Changes to This Summary (07/26/2007)






About PDQ



Page Options
Print This Page  Print This Page
Print This Document  Print Entire Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

NIH Calendar of Events

Español
NCI Highlights
New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

President's Cancer Panel Annual Report: 2006-2007

Cancer Trends Progress Report: 2007 Update

Past Highlights
HPV Vaccines for Cervical Cancer
Treatment Options by Stage

Stage I Merkel Cell Carcinoma
Stage II Merkel Cell Carcinoma
Stage III Merkel Cell Carcinoma



Stage I Merkel Cell Carcinoma

Treatment of stage I Merkel cell carcinoma may include the following:

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage I neuroendocrine carcinoma of the skin.

Stage II Merkel Cell Carcinoma

Treatment of stage II Merkel cell carcinoma may include the following:

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage II neuroendocrine carcinoma of the skin.

Stage III Merkel Cell Carcinoma

Treatment of stage III Merkel cell carcinoma is usually chemotherapy.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage III neuroendocrine carcinoma of the skin.

Back to TopBack to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov